PROVIDER PROFILE · NPI 1952528762
Michael PoieszM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,823
Unique beneficiaries
—
Total services
130,053
Distinct HCPCS
55
Medicare payment
$1.8M
Peer benchmark
Total Medicare services vs. 737 Hematology-Oncology providers in FL — top quintile (cohort median 1,932).
PRESCRIBING · PART D · 2024
Total Rx claims
775
Beneficiaries
—
Total drug cost
$1.0M
Distinct drugs
22
Brand share
33.9%
Top prescribed drugs
Anastrozole143 claims
Apixaban104 claims
Hydroxyurea66 claims
Dexamethasone50 claims
Prednisone40 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$174
Payment records
8
By payment type
Food and Beverage$174
Top paying entities
Food and Beverage$174
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
REFERRAL NETWORK
Where Michael Poiesz's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Clinical Laboratory · Tampa, FL | 11 | 42 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE